Company & Sponsor Intelligence

Rutgers, The State University of New Jersey

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials12
Recruiting3
Completed7
Countries2

Therapeutic footprint

adhdalzheimersautismmultiple_sclerosisother_psychiatryparkinsonsstroke

Indexed studies

NCT04231487Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
parkinsons · United States
UNKNOWN
NCT00464464Coping With Depression in Parkinson's Disease
parkinsons · United States
NA
NCT00004732Carotid Revascularization Endarterectomy Versus Stenting Trial
stroke · United States
NA
NCT01167608Barriers to Mental Healthcare Utilization in Parkinson's Disease
parkinsons · United States
COMPLETED
NCT04636151E-Manage: A Brief mHelath Intervention for University Students
other_psychiatry · United States
NA
NCT06072963COMMETS- Combination MCI Metabolic Syndrome
alzheimers · Israel
PHASE2
NCT04804202Virtual Cycling Environments for Persons With Parkinson Disease
parkinsons · United States
NA
NCT05512221Transdiagnostic Group Therapy (GBAT) for Autistic Adults With Personalized Therapeutics
autism · United States
NA
NCT06454604Virtual Reality Treatment for Emerging Adults With ADHD
adhd · United States
PHASE3
NCT03729713Computerized Cognitive Rehabilitation in MS Patients
multiple_sclerosis · United States
NA
NCT05597124Exercise to Improve Brain Health in Older African Americans
alzheimers · United States
PHASE2
NCT04926090Developing Mental Health Supports for Autistic Students
autism · United States
NA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →